DailyIQ
DailyIQ
METMetLife, Inc.

Earnings Release

MetLife, Inc.'s latest earnings press release, filed Nov 4, 2026, scored line by line for tone, guidance and what changed since the prior release.

No guidance given159 lines scoredFiled Nov 4, 2026SEC 8-K · Exhibit 99
Release Tone
62
UPBEAT
GuidanceNo guidance givenWhat this release does to the company's outlook
Tone change▼ 12.5pointsvs the prior release (Aug 5, 2026)
Hedging language0.88per 100 words▲ 0.53 vs prior
New this quarter108of 159 linesWording that was not in the prior release

The lines that matter most

Ranked by how material, how strongly worded and how new each sentence is.

  1. 1

    increased 12% to $14.1 billion .

    New this quarter
  2. 2

    $13.5 billion , up 8 percent .

    New this quarter
  3. 3

    Net income was $2.4 billion , driven by net derivative gains and higher adjusted earnings.

    New this quarter
  4. 4

    S ales were up 12 percent year-to-date, with strong performance in both National Accounts

    New this quarter
  5. 5

    Adjusted earnings were $413 million , down 6 percent , reflecting the impact of notable

    New this quarterNegative tone
  6. 6

    income was $6.0 billion , up 10 percent , reflecting higher VII , asset growth, and investing in a

    New this quarter
  7. 7

    Net income increased 187% 1 to $2.4 billion , or

  8. 8

    Adjusted earnings per share up 22% to $2.85 ,

Release by release

Tone and guidance for the last 3 earnings releases.

  1. Nov 4, 2026No guidance given62.3-12.5
  2. Aug 5, 2026No guidance given74.8-4.6
  3. May 6, 2026Guidance reaffirmed79.5

Bar length: tone on a 50–85 scale.

The release, annotated

1Highlight rankPositive toneNeutralNegative toneDimmed text: low materiality
Page 1 of 25
For Immediate ReleaseGlobal CommunicationsMetLife, Inc.
MetLife Announces 3Q 2026 Results
Record company performance, and top-line growth in every business segment.
Earnings
Per Share
3Q 2026
Net
Income $3.67
Adjusted
Earnings $2.78
Return
on Equity (ROE)
3Q 2026
ROE 42.7%
Adjusted
ROE 19.2%
7Net income increased 187% 1 to $2.4 billion , or
$3.67 per share.
Adjusted earnings increased 12% to $1.8 billion ,
driven by higher variable investment income,
broad-based volume growth and favorable
underwriting.
8Adjusted earnings per share up 22% to $2.85 ,
excluding total notable items — highest-ever
quarter for MetLife.
Adjusted return on equity of 19.6% , excluding
total notable items.
Premiums, fees and other revenues (PFOs)
1increased 12% to $14.1 billion .
Adjusted PFOs, excluding pension risk transfers
(PRT), increased 8% to $13.5 billion — with
growth in all si x business segments.
Book value per share (BVPS) down 22% to
Adjusted BVPS up 5% to $59.41 .
Returned approximately $1 billion to shareholders
via share repurchases and common stock
dividends.
Holding company cash and liquid assets totaled
$3.4 billion at quarter end, within our target range.
On track to deliver against free cash flow ratio and
direct expense ratio 2 targets for the year.
Comment from Michel Khalaf, President
and Chief Executive Officer:
We delivered the highest quarterly
adjusted earnings per share in MetLife’s
history in the third quarter, demonstrating
the strength of our New Frontier strategy
and discipline of our execution.
Revenue rose in every business segment,
and solid underwriting, volume growth and
higher investment returns lifted earnings.
We’re turning that into strong free cash
flow , reinvesting for responsible growth
and returning capital to shareholders.
We are firing on all cylinders in year two of
New Frontier, and we remain confident in
our strategy and its ability to drive
repeatable results.
1 In this news release, all comparisons of results for the third quarter of 2026 are with the third quarter of 2025 , unless
otherwise noted.
All year-to-date comparisons are to the first three quarters of 2025.
2 Direct expense ratio, excluding
total notable items related to direct expenses and PRT .
Page 2 of 25
Third Quarter 2026 Summary
Information regarding the non-GAAP and other financial measures included in this news release
and reconciliation of the non-GAAP financial measures to GAAP measures are in “Non-GAAP
and Other Financial Disclosures” below and in the tables that accompany this news release.
Supplemental slides for the third quarter of 2026 , titled “ 3Q26 Earnings Call Presentation,” are
available on the MetLife Investor Relations website at https://investor.metlife.com and in the
Form 8-K furnished by MetLife to the U.S. Securities and Exchange Commission in connection
with this earnings release.
Supplemental information about MetLife's diversified global
investment portfolio is contained in the " 3Q26 - General Account Assets Under Management
Fact Sheet," available on the above-mentioned website.
Page 3 of 25
Total Company Discussion
Premiums, fees and other revenues were $14.1 billion , up 12 percent compared with the
prior-year quarter.
Adjusted premiums, fees and other revenues, excluding PRT, were
2$13.5 billion , up 8 percent .
Net investment income was $6.2 billion , up 2 percent , due to higher variable investment
income (VII) and asset growth, partially offset by declines in the estimated fair value of certain
securities that do not qualify as separate accounts under GAAP.
Adjusted net investment
6income was $6.0 billion , up 10 percent , reflecting higher VII , asset growth, and investing in a
higher-rate environment .
Net investment losses were $340 million after tax, reflecting normal trading activity and a
stable credit environment.
Net derivative gains amounted to $ 551 million after tax, driven by gains on embedded
derivatives associated with ceded reinsurance, as a result of higher U.S. interest rates .
3Net income was $2.4 billion , driven by net derivative gains and higher adjusted earnings.
On a
per-share basis, net income increased 201 percent to $3.67 .
Adjusted earnings were $1.8 billion , up 12 percent on a reported basis and 13 percent on a
constant currency basis, driven by higher VII, broad-based volume growth, and favorable
underwriting.
On a per-share basis, adjusted earnings were $2.78 , up 17 percent .
Direct expense ratio , excluding total notable items related to direct expenses and PRT, was
11.9 percent , compared to 11.6 percent in the prior-year quarter, and on track for our yearly
target.
THIRD QUARTER 2026 NOTABLE ITEMS
Annual Actuarial Assumption Review and Other Insurance Adjustments
In the third quarter of 2026, MetLife performed its annual global actuarial assumption review.
The actuarial assumption review and other insurance adjustments during the quarter reduced
net income by $56 million and adjusted earnings by $46 million.
Page 4 of 25
Adjusted Earnings by Segment Summary
Three Months Ended September 30, 2026
SegmentChange from prior-year period (on a reported basis)Change from prior-year period (on a constant currency basis)
Group Benefits15%
Retirement and Income Solutions (RIS)(6)%
Asia11%14%
Latin America45%30%
Europe, the Middle East and Africa (EMEA)24%32%
MetLife Investment Management (MIM)9%
Business Discussions
GROUP BENEFITS
($ in millions)Three Months Ended September 30, 2026Three Months Ended September 30, 2025Change
Adjusted earnings$523$45615%
Notable item(s)$0$(2)
Adjusted earnings ex. notables$523$45814%
Adjusted PFOs$6,513$6,3063%
Adjusted PFOs, excluding participating contracts$5,083$4,8645%
Adjusted earnings were $523 million , up 15 percent .
Excluding notable items, adjusted earnings were $523 million, up 14 percent , primarily
driven by favorable underwriting.
Adjusted PFOs were $6.5 billion .
Adjusted PFOs, excluding participating contracts, were $5.1 billion , up 5 percent ,
reflecting growth in core and voluntary products .
4S ales were up 12 percent year-to-date, with strong performance in both National Accounts
and Regional Business.
RIS
($ in millions)Three Months Ended September 30, 2026Three Months Ended September 30, 2025Change
Adjusted earnings$413$441(6)%
Notable item(s)$(65)$13
Adjusted earnings ex. notables$478$42812%
Adjusted PFOs$2,018$1,21466%
Adjusted PFOs, excluding PRT$1,624$1,22433%
5Adjusted earnings were $413 million , down 6 percent , reflecting the impact of notable
items from the annual actuarial assumption review.
Page 5 of 25
Excluding notable items, adjusted earnings were $478 million, up 12 percent , driven by
higher VII and volume growth.
Adjusted PFOs were $2.0 billion .
Adjusted PFOs, excluding PRT, were $1.6 billion , up 33 percent , mainly driven by higher
sales of post-retirement benefits and U.K. longevity reinsurance.
Total retained liability exposure grew 7 percent .
ASIA
Adjusted earnings were $602 million , up 11 percent on a reported basis and up 14 percent
on a constant currency basis, reflecting the impact of the annual actuarial assumption review
and other insurance adjustments.
Excluding notable items, adjusted earnings were $550 million, up 17 percent on a
reported basis and up 21 percent on a constant currency basis, driven by higher VII, strong
equity markets and volume growth, partially offset by less favorable underwriting.
Adjusted PFOs were $1.7 billion , up 1 percent on a reported basis and up 5 percent on a
constant currency basis.
Asia general account assets under management (at amortized cost) were
1 boilerplate lines (safe-harbor disclaimer, contacts, call details) are set aside.

How this is scored

  • Source: the press release MetLife, Inc. filed with the SEC as Exhibit 99 to Form 8-K (Item 2.02). Financial statements and boilerplate are set aside.
  • Tone: a financial sentiment model scores each sentence 0 to 100; the release score weights sentences by how material they are.
  • Materiality and guidance: a classifier judges whether each sentence is specific information, and what the release does to the outlook.
  • New this quarter: wording that does not appear in the prior release.
  • Hedging: uncertainty words (may, could, approximately, headwinds and similar) per 100 words of narrative.

These scores describe the release's language. They are not a forecast or a recommendation. Read the original filing

Back to MET overview